These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33726954)

  • 1. The impact of 10-valent pneumococcal conjugate vaccine upon hospitalization rate of children with pneumonia in different Brazilian administrative regions.
    Ferreira MN; Netto EM; Nascimento-Carvalho CM
    Vaccine; 2021 Apr; 39(15):2153-2164. PubMed ID: 33726954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
    Andrade AL; Afonso ET; Minamisava R; Bierrenbach AL; Cristo EB; Morais-Neto OL; Policena GM; Domingues CMAS; Toscano CM
    PLoS One; 2017; 12(9):e0184204. PubMed ID: 28880953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.
    Scotta MC; Veras TN; Klein PC; Tronco V; Polack FP; Mattiello R; Pitrez PMC; Jones MH; Stein RT; Pinto LA
    Vaccine; 2014 Jul; 32(35):4495-4499. PubMed ID: 24958703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of administrative data for vaccine impact evaluation: the case of pneumonia hospitalizations and pneumococcal vaccine in Brazil.
    Sgambatti S; Minamisava R; Afonso ET; Toscano CM; Bierrenbach AL; Andrade AL
    Epidemiol Infect; 2015 Jan; 143(2):334-42. PubMed ID: 24759601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.
    Sgambatti S; Minamisava R; Bierrenbach AL; Toscano CM; Vieira MA; Policena G; Andrade AL
    Vaccine; 2016 Jan; 34(5):663-670. PubMed ID: 26706272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pneumococcal vaccine in reducing pneumonia hospitalizations in children under 5 years old, in Santa Catarina, Brazil, 2006 a 2014.
    Vieira ILV; Kupek E
    Epidemiol Serv Saude; 2018 Nov; 27(4):e2017378. PubMed ID: 30517348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.
    Afonso ET; Minamisava R; Bierrenbach AL; Escalante JJ; Alencar AP; Domingues CM; Morais-Neto OL; Toscano CM; Andrade AL
    Emerg Infect Dis; 2013 Apr; 19(4):589-97. PubMed ID: 23628462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.
    Luca DL; Kwong JC; Chu A; Sander B; O'Reilly R; McGeer AJ; Bloom DE
    Clin Infect Dis; 2018 Feb; 66(4):541-547. PubMed ID: 29029063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016.
    Mpabalwani EM; Lukwesa-Musyani C; Imamba A; Nakazwe R; Matapo B; Muzongwe CM; Mufune T; Soda E; Mwenda JM; Lutz CS; Pondo T; Lessa FC
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S58-S65. PubMed ID: 31505628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
    van Deursen AMM; Schurink-Van't Klooster TM; Man WH; van de Kassteele J; van Gageldonk-Lafeber AB; Bruijning-Verhagen PCJL; de Melker HE; Sanders EAM; Knol MJ
    Vaccine; 2017 Dec; 35(51):7107-7113. PubMed ID: 29146381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis.
    Alicino C; Paganino C; Orsi A; Astengo M; Trucchi C; Icardi G; Ansaldi F
    Vaccine; 2017 Oct; 35(43):5776-5785. PubMed ID: 28911902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children.
    Silva SR; Mello LM; Silva AS; Nunes AA
    Rev Paul Pediatr; 2016 Dec; 34(4):418-424. PubMed ID: 27108092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil.
    Warren JL; Shioda K; Kürüm E; Schuck-Paim C; Lustig R; Taylor RJ; Simonsen L; Weinberger DM
    Clin Infect Dis; 2017 Nov; 65(11):1813-1818. PubMed ID: 29020195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges to estimating vaccine impact using hospitalization data.
    Schuck-Paim C; Taylor RJ; Simonsen L; Lustig R; Kürüm E; Bruhn CA; Weinberger DM
    Vaccine; 2017 Jan; 35(1):118-124. PubMed ID: 27899227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.
    Diaz J; Terrazas S; Bierrenbach AL; Toscano CM; Alencar GP; Alvarez A; Valenzuela MT; Andrus J; del Aguila R; Hormazábal JC; Araya P; Pidal P; Matus CR; de Oliveira LH
    PLoS One; 2016; 11(4):e0153141. PubMed ID: 27058873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern Mozambique.
    Massora S; Lessa FC; Moiane B; Pimenta FC; Mucavele H; Chaúque A; Cossa A; Verani JR; Tembe N; da Gloria Carvalho M; Muñoz-Almagro C; Sigaúque B
    Vaccine; 2019 Dec; 37(51):7470-7477. PubMed ID: 31575493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
    Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
    Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study.
    Schuck-Paim C; Taylor RJ; Alonso WJ; Weinberger DM; Simonsen L
    Lancet Glob Health; 2019 Feb; 7(2):e249-e256. PubMed ID: 30683242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine.
    Medeiros MIC; Almeida SCG; Guerra MLLS; da Silva P; Carneiro AMM; de Andrade D
    BMC Infect Dis; 2017 Aug; 17(1):590. PubMed ID: 28841854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.